LivaNova greenshoe raises 2.5% convertibles to $345 million

Chicago, March 11 – The initial purchasers of LivaNova plc’s new 2.5% five-year convertible notes exercised the $45 million greenshoe option in full, according to an 8-K filing with the Securities and Exchange Commission.

The exercise brought the total size of the offering to $345 million.

Goldman Sachs & Co. LLC, Barclays and BofA Securities Inc. were bookrunners for the Rule 144A offering.

The proceeds were used to cover the cost of the call spread for approximately $31.6 million, to fund the repurchase of the 3% exchangeable notes due 2025 for approximately $270.5 million and for general corporate purposes.

LivaNova is a London-based medical technology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.